MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells.

MLA

Mao, Yuan, et al. “MAGE-A1 in Lung Adenocarcinoma as a Promising Target of Chimeric Antigen Receptor T Cells.” Journal of Hematology & Oncology, vol. 12, no. 1, Oct. 2019, p. 106. EBSCOhost, https://doi.org/10.1186/s13045-019-0793-7.

APA

Mao, Y., Fan, W., Hu, H., Zhang, L., Michel, J., Wu, Y., Wang, J., Jia, L., Tang, X., Xu, L., Chen, Y., Zhu, J., Feng, Z., Xu, L., Yin, R., & Tang, Q. (2019). MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells. Journal of Hematology & Oncology, 12(1), 106. https://doi.org/10.1186/s13045-019-0793-7

Chicago

Mao, Yuan, Weifei Fan, Hao Hu, Louqian Zhang, Jerod Michel, Yaqin Wu, Jun Wang, et al. 2019. “MAGE-A1 in Lung Adenocarcinoma as a Promising Target of Chimeric Antigen Receptor T Cells.” Journal of Hematology & Oncology 12 (1): 106. doi:10.1186/s13045-019-0793-7.